PetCure Oncology and Radialogica Partner to Fight Cancer in Pets

CHICAGO–(BUSINESS WIRE)–PetCure
Oncology
, the leader in providing cancer care for pets, is pleased
to announce the selection of Radialogica’s
fullAccess
software as the company’s platform for clinical collaboration and
quality management. PetCure Oncology formally implemented fullAccess™
across its network of cancer centers earlier this month.

fullAccess, successfully used to manage the quality and efficiency of
radiation therapy in human cancer treatment, is a fully-integrated
radiotherapy data display, communication and analysis platform that
enables clinicians across the continuum of care to quickly and easily
access, analyze, and share radiation therapy treatment plans and other
medical records. Designed to simplify, streamline, and standardize the
plan review process, fullAccess features a vendor-independent RT
visualization environment that supports flexible review of diagnostic
images and treatment plans from any location, robust analytics to
evaluate and benchmark the quality and safety of radiation treatment
plans, and clinical collaboration tools that facilitate access to
clinical expertise and distribution of best practices.

“Partnering with Radialogica allows us to take the best practices from
human oncology treatment planning and apply it to veterinary medicine,”
said PetCure Oncology Chief Medical Officer Neal
Mauldin
. “Safety, exceptional quality and collaboration to optimize
outcomes are extremely important to us, and Radialogica shares these
important ideals. Their service has been outstanding and the fullAccess
platform allows us to safely and effectively treat more pets through a
truly collaborative and comprehensive approach.”

“To date, our focus has been on enhancing the quality of radiotherapy
treatment and efficiency of clinical workflow within the human
healthcare industry,” stated Andy
Cowen
, CEO of Radialogica. “We are thrilled to support the
application of fullAccess within the veterinary field through PetCure
Oncology and believe it is a testament to their team’s rigor and focus
on quality of care.”

The progressive software complements PetCure Oncology’s mission to
revolutionize cancer care for pets, which includes offering stereotactic
radiosurgery (SRS)
, an advanced form of radiation therapy. Widely
used in human cancer treatment, SRS offers tremendous benefits to pets
by delivering high doses of radiation with sub-millimeter precision in a
non-invasive, non-surgical manner. In addition to treating the patient
with the intent to cure, SRS requires only 1-3 treatment sessions
compared to 15-21 with conventional radiation therapy (CFRT), while
minimizing both the risk and the side effects commonly associated with
CFRT.

About PetCure Oncology

Cancer accounts for nearly 50 percent of all disease-related pet deaths
and is the leading cause of death in older dogs and cats. PetCure
Oncology is revolutionizing cancer care for pets by establishing
veterinary SRS centers across the country. Centers in Phoenix,
Cincinnati,
and Clifton,
NJ
, are operational. Locations in
Wisconsin and Illinois are scheduled to open in the next few months,
with many more in various stages of development across the country. To
learn more or obtain a referral to PetCure Oncology, visit PetCureOncology.com
or call (773) 850-3400.

About Radialogica

Radialogica,
a privately held St. Louis-based healthcare analytics company, is
focused on radiation therapy for cancer patients. Its mission is to
empower healthcare providers and payers to manage the care and cost of
cancer treatment and survivorship. For additional information, visit Radialogica.com.

Contacts

PetCure Oncology
JoAnn Stewart, RVT, CVPM
Chief Operating
Officer
847-275-8600
jstewart@PetCureOncology.com